Eli Lilly (LLY)
(Delayed Data from NYSE)
$726.31 USD
-19.64 (-2.63%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $725.50 -0.81 (-0.11%) 4:48 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 22% (195 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.20 | 2.10 | 9.99 |
Current Quarter Estimate | 2.54 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 1.62 | 11.39 | 52.54 |
Next Quarter Estimate | 2.68 | 34.85 | 61.00 |
Next Year Estimate | 18.50 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 98.10 | 3.90 | 17.08 |
Next Year | 47.76 | 16.00 | 8.00 |
Last 5 Years | 3.60 | 3.00 | 8.10 |
Next 5 Years | 36.60 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 118.03 | 15.53 |
Price/Book (MRQ) | 65.18 | 5.31 |
Price/Cash Flow (MRFY) | 97.81 | 10.05 |
Dividend Yield | 0.70% | 2.83% |
Net Profit Margin (TTM) | 15.36% | NA |
Return on Equity (TTM) | 51.22% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.